Viridian Therapeutics, Inc.\DE (VRDN) FCF Payout Ratio (2013)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly FCF Payout Ratio came in at 0.12 in Q4 2013, up 38.4% quarter-over-quarter from 0.2 in Q3 2013.
Viridian Therapeutics, Inc.\DE (VRDN) FCF Payout Ratio (2013) Analysis & Trends
Viridian Therapeutics, Inc.\DE's FCF Payout Ratio history runs 1 years deep, the most recent figure standing at 0.12 for Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.12 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 229.55 Mn | 229.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -0.12 |
| Sep 30, 2013 | -0.20 |